ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 8 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $90,000 | +21.6% | 150,000 | 0.0% | 0.04% | +100.0% |
| Q2 2022 | $74,000 | -45.2% | 150,000 | 0.0% | 0.02% | -60.4% |
| Q1 2022 | $135,000 | -28.9% | 150,000 | -11.8% | 0.05% | +3.9% |
| Q4 2021 | $190,000 | -54.8% | 170,000 | -28.0% | 0.05% | -56.8% |
| Q3 2021 | $420,000 | -39.7% | 236,165 | +11.8% | 0.12% | -32.2% |
| Q2 2021 | $697,000 | +4.0% | 211,165 | +5.6% | 0.17% | -6.5% |
| Q1 2021 | $670,000 | +737.5% | 200,000 | +1900.0% | 0.19% | +332.6% |
| Q3 2018 | $80,000 | -59.0% | 10,000 | -54.3% | 0.04% | -49.4% |
| Q2 2018 | $195,000 | – | 21,900 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |